Recent Quarter Total Invested
$208.89 M
Recent Quarter Institutional Ownership Percentage
88.4%
Total Invested of Last Quarter
$410.49 M
Ownership Percentage of Last Quarter
98.25%
Revance Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CAPITAL WORLD INVESTORS | 08/13/2024 | 13.94 M | $35.82 M | -0.05% | 15.16% |
| BLACKROCK INC. | 08/13/2024 | 8.57 M | $22.01 M | 17.13% | 9.32% |
| FRANKLIN RESOURCES INC | 08/14/2024 | 6.26 M | $16.09 M | -0.39% | 6.81% |
| VANGUARD GROUP INC | 08/13/2024 | 5.99 M | $15.41 M | 11.04% | 6.52% |
| PALO ALTO INVESTORS LP | 08/14/2024 | 5.26 M | $13.51 M | 0.17% | 5.72% |
| POLAR CAPITAL HOLDINGS PLC | 08/14/2024 | 3.57 M | $9.17 M | -8.18% | 3.88% |
| JPMORGAN CHASE & CO | 08/12/2024 | 2.94 M | $7.57 M | -6.60% | 3.20% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 08/21/2024 | 2.80 M | $7.20 M | 41.68% | 3.05% |
| RUBRIC CAPITAL MANAGEMENT LP | 08/13/2024 | 2.66 M | $6.83 M | 0.00% | 2.89% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 2.30 M | $5.91 M | 16.60% | 2.50% |
| STATE STREET CORP | 08/14/2024 | 2.28 M | $5.87 M | -3.19% | 2.48% |
| FEDERATED HERMES, INC. | 08/08/2024 | 2.24 M | $5.75 M | 43.00% | 2.43% |
| NUVEEN ASSET MANAGEMENT, LLC | 08/09/2024 | 1.06 M | $2.71 M | 199.98% | 1.15% |
| BAMCO INC /NY/ | 08/14/2024 | 1.02 M | $2.63 M | 0.00% | 1.11% |
| MORGAN STANLEY | 08/14/2024 | 977,095 | $2.51 M | -18.84% | 1.06% |
| GOLDMAN SACHS GROUP INC | 08/13/2024 | 933,618 | $2.40 M | 71.80% | 1.02% |
| NORTHERN TRUST CORP | 08/14/2024 | 866,186 | $2.23 M | 0.11% | 0.94% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2024 | 756,912 | $1.95 M | 396.78% | 0.82% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2024 | 749,587 | $1.93 M | 7.08% | 0.82% |
| RICE HALL JAMES & ASSOCIATES, LLC | 08/07/2024 | 712,072 | $1.83 M | -4.57% | 0.77% |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 08/13/2024 | 701,707 | $1.80 M | 0.00% | 0.76% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2024 | 633,903 | $1.63 M | 146.27% | 0.69% |
| WALLEYE CAPITAL LLC | 08/14/2024 | 610,792 | $1.57 M | -1.82% | 0.66% |
| PERCEPTIVE ADVISORS LLC | 08/16/2024 | 600,000 | $1.54 M | 0.00% | 0.65% |
| RENAISSANCE TECHNOLOGIES LLC | 08/09/2024 | 572,000 | $1.47 M | 53.06% | 0.62% |
| HIGHTOWER ADVISORS, LLC | 08/13/2024 | 535,387 | $1.38 M | 20.21% | 0.58% |
| EULAV ASSET MANAGEMENT | 08/13/2024 | 500,000 | $1.29 M | 0.00% | 0.54% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 08/14/2024 | 500,000 | $1.29 M | 100.00% | 0.54% |
| ESSEX WOODLANDS MANAGEMENT, INC. | 08/14/2024 | 457,085 | $1.17 M | 0.00% | 0.50% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 08/13/2024 | 441,584 | $1.14 M | 100.00% | 0.48% |
| GRAHAM CAPITAL MANAGEMENT, L.P. | 08/14/2024 | 417,161 | $1.07 M | 100.00% | 0.45% |
| TANG CAPITAL MANAGEMENT LLC | 08/14/2024 | 400,000 | $1.03 M | 100.00% | 0.44% |
| CM MANAGEMENT, LLC | 08/01/2024 | 400,000 | $1.03 M | 60.00% | 0.44% |
| BANK OF NEW YORK MELLON CORP | 07/25/2024 | 373,015 | $958,649 | 22.48% | 0.41% |
| UBS OCONNOR LLC | 08/14/2024 | 325,314 | $836,057 | 27.74% | 0.35% |
| LANE GENERATIONAL LLC | 07/31/2024 | 319,322 | $820,658 | 100.00% | 0.35% |
| BLAIR WILLIAM & CO/IL | 08/12/2024 | 290,515 | $746,622 | -11.77% | 0.32% |
| MOORE CAPITAL MANAGEMENT, LP | 08/14/2024 | 250,000 | $642,500 | 0.00% | 0.27% |
| DCF ADVISERS, LLC | 08/12/2024 | 250,000 | $642,500 | -5.08% | 0.27% |
| CITADEL ADVISORS LLC | 08/14/2024 | 249,029 | $640,005 | 391.54% | 0.27% |
| ALPHACENTRIC ADVISORS LLC | 07/25/2024 | 245,000 | $629,650 | 0.00% | 0.27% |
| UBS ASSET MANAGEMENT AMERICAS INC | 08/14/2024 | 237,790 | $611,120 | 99.22% | 0.26% |
| GHOST TREE CAPITAL, LLC | 08/14/2024 | 225,000 | $578,250 | -50.00% | 0.24% |
| AQR CAPITAL MANAGEMENT LLC | 08/14/2024 | 201,080 | $516,775 | 567.60% | 0.22% |
| ASSENAGON ASSET MANAGEMENT S.A. | 07/18/2024 | 198,846 | $511,034 | 0.00% | 0.22% |
| PDT PARTNERS, LLC | 08/15/2024 | 197,049 | $506,416 | 100.00% | 0.21% |
| SWISS NATIONAL BANK | 08/08/2024 | 194,650 | $500,251 | 0.00% | 0.21% |
| SCHONFELD STRATEGIC ADVISORS LLC | 08/14/2024 | 193,591 | $497,528 | 100.00% | 0.21% |
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 179,951 | $462,475 | -64.34% | 0.20% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2024 | 176,973 | $454,820 | 47.59% | 0.19% |
Revance Therapeutics, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of RVNC shares?
During the previous two years, 255 institutional investors and hedge funds held shares of Revance Therapeutics, Inc.. The most heavily invested institutionals were:
Capital World Investors: 13.94 M
BlackRock Inc.: 8.57 M
FRANKLIN RESOURCES INC: 6.26 M
VANGUARD GROUP INC: 5.99 M
Palo Alto Investors LP: 5.26 M
Polar Capital Holdings Plc: 3.57 M
-
What percentage of Revance Therapeutics, Inc. stock is owned by institutional investors?
88.40% of Revance Therapeutics, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at RVNC ?
Institutional investors have bought a total of 89.35 M shares in the last 24 months. This purchase volume represents approximately $465.53 M in transactions.